Abeona Therapeutics (ABEO) Tops Q1 EPS by 13c

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.24), $0.13 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
• BMO Capital on Darden Restaurants (DRI): 'Modestly Lowering FY4Q26 Estimates'
• BofA Securities on MP Materials (MP): expecting little to no impact from China export control list news